MedTrace Logo

Migraine Headache Mitigation Utilizing Avulux

NCT06149000 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-28

No results posted yet for this study

Summary

This will be a randomized double blind cross over interventional trial to determine if Avulux lenses are able to reduce headache symptoms in patients

Conditions

Interventions

DEVICE

Avulux Lenses

Avulux lenses are specialized eyewear designed to reduce specific wavelengths of light to alleviate symptoms in individuals who experience light sensitivity and migraines

DEVICE

Placebo Lenses

Lenses that will look identical to Avulux lenses without the medical benefits

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Munish Sharma, OD/MBA · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2024-06-13
Completion
2024-06-20
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06149000 on ClinicalTrials.gov